Vireo Growth Inc. 8-K

What Happened Vireo Growth Inc. (VREOF) announced that the previously disclosed merger to acquire Eaze closed on April 1, 2026. The Company issued 90,379,591 subordinate voting shares as the Estimated Closing Merger Consideration (based on an Estimated Closing Merger Consideration of US$47,040,000 divided by US$0.56). A 10% portion (81,341,632 shares) was placed in escrow and 9,037,959 shares were delivered to the payment agent for distribution to former Eaze stockholders. Vireo also executed a First Amendment to the Merger Agreement to amend earnout payment mechanics and filed related investor-rights and lock-up arrangements. Separately, the Board appointed Michael Steiner as a director (effective April 3, 2026) and approved significant amendments to CEO John Mazarakis’s employment package, including a large salary increase and multi-phase equity awards.

Key Details

• Merger closing: April 1, 2026; 90,379,591 subordinate voting shares issued as estimated closing consideration.
• Base consideration: Estimated Closing Merger Consideration includes a US$47,040,000 Base Consideration and is subject to post-closing purchase price adjustments.
• Earnout: Former Eaze stockholders may receive additional shares based on an imputed EBITDA target of US$76,800,000 (earnout paid using the higher of US$1.05 or the 20-day VWAP before Dec 31, 2026); number of earnout shares cannot exceed shares issued at closing.
• CEO compensation: John Mazarakis’s base salary increased from US$1 to US$2,250,000 (effective at market-cap trigger or Jan 1, 2027); starting Jan 1, 2027 the Company will issue 10,000,000 shares annually for five years (subject to ADTV and other conditions) and granted conditional multi‑phase performance RSU awards (Phase 1 = 1.5% of fully diluted equity; Phase 2 = 2.5%; Phase 3 = two 2.5% tranches) tied to market-cap, EBITDA, ADTV and TSR goals.

Why It Matters The Eaze closing makes Eaze a wholly owned subsidiary of Vireo and involved a material issuance of shares that dilutes existing holders (90.4 million shares issued; 10% escrowed). The amended earnout and escrow/lock-up schedules mean additional shares could be issued later if Eaze meets performance targets, increasing potential dilution tied to future EBITDA performance. The CEO’s amended compensation and large, performance-linked equity awards could materially affect share count if performance targets are met; they also align a sizeable portion of executive pay with long-term market-cap and EBITDA goals. Finally, Vireo restructured its New York subsidiary (VHNY) ownership with a partner (Ace) and VHNY issued a ~$16M intercompany note to Vireo, which could affect cash flows and recoveries under the VHNY arrangement. Investors should note dilution, performance conditions, and timing (earnout measurement around Dec 31, 2026 and multi-year vesting through 2030) when assessing the impact on share value.